Debate Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments

被引:4
|
作者
Kawaguchi, Yoshikuni [1 ,2 ]
De Bellis, Mario [1 ]
Panettieri, Elena [1 ]
Duwe, Gregor [1 ]
Vauthey, Jean-Nicolas [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan
基金
美国国家卫生研究院;
关键词
Colorectal liver metastasis; Resection; Chemotherapy; Molecular-targeted therapy; Conversion therapy; Two-stage hepatectomy; Neuroendocrine liver metastasis; Gastric liver metastasis; HEPATIC VEIN EMBOLIZATION; RANDOMIZED PHASE-III; COLORECTAL-CANCER; 2-STAGE HEPATECTOMY; GASTRIC-CANCER; NEUROENDOCRINE METASTASES; SURGICAL RESECTION; 1ST-LINE TREATMENT; MAJOR HEPATECTOMY; PLUS BEVACIZUMAB;
D O I
10.1016/j.soc.2020.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:205 / 218
页数:14
相关论文
共 50 条
  • [21] Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation
    Thuluvath, Paul J.
    To, Chau
    Amjad, Waseem
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (01): : 57 - 67
  • [22] Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements
    Abdalla, Eddie K.
    Bauer, Todd W.
    Chun, Yun S.
    D'Angelica, Michael
    Kooby, David A.
    Jarnagin, William R.
    HPB, 2013, 15 (02) : 119 - 130
  • [23] Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
    Abdel-Rahman, Omar
    Cheung, Winson Y.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [24] LOCOREGIONAL TREATMENTS WITH CURATIVE INTENT IN PATIENTS WITH LIVER METASTASES FROM COLORECTAL CANCER: ARE COMBINATION TREATMENTS A VIABLE TREATMENT OPTION?
    Tenore, L.
    Posa, A.
    Carchesio, F.
    Tanzilli, A.
    Longo, V.
    Cassano, A.
    Iezzi, R.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S185 - S186
  • [25] Clinical and radiological response to locoregional and systemic treatments in well-differentiated gastroenteropancreatic neuroendocrine tumors with liver metastases treated at a reference center in Mexico.
    Arce Sandoval, Cesar
    Meneses Medina, Monica Isabel
    Cisneros Cordero, Miriam Heidi
    Humberto Hernandez-Felix, Jorge
    Rosas Camargo, Vanessa
    Torres Valdiviezo, Lucero Itzel
    Ramirez, Rixci
    Gabutti Thomas, Jesus Alejandro
    Huitzil Melendez, Fidel David David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 644 - 644
  • [26] Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
    Schwarz, Roderich E.
    Berlin, Jordan D.
    Lenz, Heinz J.
    Nordlinger, Bernard
    Rubbia-Brandt, Laura
    Choti, Michael A.
    HPB, 2013, 15 (02) : 106 - 115
  • [27] Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
    Cavalcoli, Federica
    Rausa, Emanuele
    Conte, Dario
    Nicolini, Antonio Federico
    Massironi, Sara
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (15) : 2640 - 2650
  • [28] Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
    Federica Cavalcoli
    Emanuele Rausa
    Dario Conte
    Antonio Federico Nicolini
    Sara Massironi
    World Journal of Gastroenterology, 2017, 23 (15) : 2640 - 2650
  • [29] Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement
    Clary, Bryan M.
    Grothey, Axel
    Kopetz, Scott
    Marsh, Robert D. W.
    HPB, 2013, 15 (02) : 116 - 118
  • [30] Management of bone metastases in renal cell carcinoma: bone-targeted treatments, systemic therapies, and radiotherapy
    Mansinho, Andre
    Nejo, Priscila
    Leitao, Tito
    Casimiro, Sandra
    Costa, Luis
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7